To compare the findings of the clinical trials in terms of the effectiveness of N. sativa on the secondary outcomes of NAFLD such as fasting blood glucose (FBG), serum insulin, homeostatic model assessment for insulin resistance (HOMA-IR), lipid profiles, blood pressure, inflammatory biomarkers and anthropometric indices; and 3. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.